Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Digital education aims to boost Hospital-at-Home care across scandinavia

NCT ID NCT07166653

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether an online education program for hospital staff can increase the use of hospital-at-home (HaH) services, where patients receive hospital-level care at home. Researchers will compare 14 hospitals in Denmark, Norway, and Sweden that receive the training against those that continue usual care. The main goal is to see if the training leads to more eligible patients being treated at home, with secondary measures including staff knowledge, motivation, and patient outcomes like readmission and mortality.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
online education program (NorDigHE HaH education)
What this could lead to
If successful, this could show that online training helps hospitals shift more care to patients' homes, reducing hospital stays and improving efficiency.
What could go wrong
This is a small, early-stage trial with only 14 hospitals, so results may not apply broadly. The education may not change staff behavior or patient outcomes as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 14 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: Hospitals with clinical departments treating acutely ill in-patients that have, or are ready to establish, the prerequisites and infrastructure for HaH - regardless of the specific approach, envisioned HaH model, primary sector collaborations, or local sector collaboration agreements and frameworks. Each hospital must have or be ready to establish: 1. a governance structure to organize and oversee HaH-services. 2. an IT-platform capable of managing data from and to HaH patients. 3. a safe communication pathway between HaH-patient and the hospital. 4. clear agreements on types of data to be exchanged between HaH-patient and hospital. 5. agreements on roles, responsibilities, and capacity (incl. possibly primary sector entities). 6. clinical guidelines, standard operating procedures, and action plans to support the HaH work. Exclusion Criteria: * Hospitals that do not have or are not ready to secure relevant pre-requisites listed above (a to f).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hospital are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nordsjællands Hospital

    RECRUITING

    Hillerød, Capitol Region of Denmark, 3400, Denmark

  • Sahlgrenska University hospital

    RECRUITING

    Göteborg, Skåne County, Sweden

  • University College of Østfold

    RECRUITING

    Fredrikstad, Østfold fylke, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.